Emergence of Probiotics in Therapeutic Applications
DOI:
https://doi.org/10.37285/ijpsn.2009.2.1.1Abstract
The gastrointestinal tract of human body is considered as an ecosystem which had been developed physiologically and microbiologically. The probiotic organisms (lactic acid bacteria) are one of the most important groups present in the gastrointestinal tract. A good number of Lactobacillus species, Bifidobacterium species, Saccharomyces boulardii and some other microbes are now used as probiotic strains. These probiotic organisms are marketed as health care products, functional foods or food supplements. The details of clinical, therapeutic applications and safety aspects of probiotics are discussed.
Downloads
Download data is not yet available.
Metrics
Metrics Loading ...
Keywords:
Probiotics, Lactic acid bacteria, Gastrointestinal tract, GRAS, Clinical practice
Downloads
Published
2009-05-31
How to Cite
1.
Bhattacharyya BK. Emergence of Probiotics in Therapeutic Applications. Scopus Indexed [Internet]. 2009 May 31 [cited 2024 May 19];2(1):383-9. Available from: http://www.ijpsnonline.com/index.php/ijpsn/article/view/268
Issue
Section
Review Articles
References
Abd El-Gawad IA, El-Sayed EM, Hafez SA, El-Zeini HM and Saleh FA. The hypocholesterollaemic effect of milk yoghurt and soy-yoghurt containing bifidobacteria in rats fed on a cholesterol-enriched diet. Int. Dairy J. 15: 37 -44 (2005).
Allen SJ, Okoko B, Martinez E, Gregorio G and Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Sys. Rev. 2: CD003048 (2004).
Blakey JL, Lubitz L, N. Campbell NT, Gillam GL, Bishop RF and Barnes GL. Enteric colonization in sporadic neonatal necrotizing enterocolitis. J. Pediatr. Gastroenterol. Nutr. 4: 591 – 595 (1985).
Drasar BS and Shah NP. Human intestinal flora, Academic press, New York, NY, 1974.
Friend BA, Fermer R and Shahami K. Effect of feeding and intraperitonial implantation of yogurt culture cells on Ehrlich ascites tumor. Milchwissens Chaft. 37: 708 -710 (1982).
Giacinto CD, Marinaro M, Sanchez M, Strober W and Boirivant M. Probiotic ameliorate recurrent Th1 – mediated murine colitis by inducing IL-10 and IL – 10 dependent TGF-beta bearing regulatory cells. J. Immunol. 174 (6): 3237 -3246 (2005).
Gill HS and Guarner F. Probiotics and human health: a clinical prespective, Postgraduate Med J. 80: 516 – 526 (2004).
Gilliland SE and Speck ML. Deconjugation of bile acids by intestenal lactobacilli. Appl. Environ. Microbiol. 33: 15 (1977).
Gilliland SE, Nelson CR, and Maxwell C. Assimilation of cholesterol by Lactobacillus acidophilus. Appl. Environ. Microbiol. 49: 337 – 381 (1985).
Goltz V, Romankiewiez JA, Moss J and Murr HV. Prophylaxis against ampicillin associated diarrhea with Lactobacillus preparation. Am. J. Hosp. Pharm. 36: 754 (1974).
Guarino A, Canani RB, Spagnuolo MI, Albano F and Benedetto LD. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J. Pediatr. Gastroenterol. Nutr. 25: 516-519 (1997).
Harmsen HJM, Raangas GC, He T, Degener JE and Welling GW. Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl. Environ. Microbiol. 68: 2982 – 2990 (2002).
Hennequin C, Kauffman-Lacroix C, Jobett A, Viard JP, Ricour C, Jaequemin JL and Berohe P. Possible role of Catheters in Saccharomyes boulardii fungemia. Eu. J. Clin. Microbiol. Infect. Dis. 40 (4): 970-975 (2000).
Hepner G, Fried R, Jeors S, Fuselt L and Morin R. Hypercholesterolemic effect of yogurt and milk. Am. J. Clin. Nutr. 32: 19 -24 (1979).
Holzer M, Mayrhuber E, Danner H and Braun H. The role of Lactobacillus buchneri in forge preservation. Trends Biotechnol. 21 (6): 282 -286 (2003).
Hosono A, Kashina T and Kada T. Antimutagenic properties of lactic acid cultered milk on chemical and fecal mutgens. J. Dairy Sci. 69: 2237 -2242 (1986).
Hosono A, Yoshimura A and Tani O. Antimutagenic activity of cellular component of Streptococcus faecalis IFO12965. Netherlands Milk and Dairy Journal. 41: 239 -245 (1987).
Kilara A and Shahani KM. Lactose activity of cultured and acidified dairy products. J. Dairy Sci. 61: 2031 – 2035 (1976).
Kruis W, Fric P, Pokotnicks J, Lukas M, Fixa B, Kascak M, Kamm MA, Weismulen J, Beglinger C, Stolte M, Wolf C and Wchulze J. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is an effective as with standard mesalazine. Gut. 53 (110): 1617 – 1623 (2004).
Kruszewska D, Lan, J, Lorca G, Yanagisawa N, Marklinder I and Ljungh A. Selection of lactic acid bacteria as probiotic strains by in vitro tests. Microb. Ecol. Health Dis. 29: 37 -49 (2002).
Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM. Lactobacillus endocarditis caused by a probiotic organism. Clin. Microbiol. Infect. 5(5): 290 – 292 (1999).
Majamaa H, Isolauri E, Saxelin M and Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroentitis. J. Pediatr. Gastroenterol. Nutr. 20: 333-338 (1995).
Mastsumoto S, Hara T, Hori T, Mitsuyama K, Nagaka M, Tomiyasu N, Suzuki A and Sata M. 2005. Probiotic Lactobacillus-induced improved in murine chronic inflammatory bowel disease is associated with down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin. Exp. Immunol. 14: 417 -426 (2005).
Meydani SN and Ha WK. Immunologic effects of yogurt. Am. J. clin. Nutr. 17: 861 -872 (2000).
Michalkiewicz J, Kortkiewski M, Gackowska L, Wayszomirska-Golda M, Helmin-Bara A, Dzierzanowa D and Madalinski K. Immunomodulatory effectds of lactic acid bacteria on human pherpheral blood mononuclear cells. Microb. Ecol. Health Dis. 15: 185-192 (2003).
Mimura T, Kaminishi M and Kamm MA. Diagnostic evaluation of patients with faecal incintinence at a specialist institution. Dig. Surg. 21 (30): 235 -241 (2004).
Osvath R. FDA food advisory committee to discuss criteria for safety of probiotics. Food Chem. News. 42: 12 (2000).
Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am. J. Gastroenterol. 95: S11 – S13 (2000).
Pulusani SR and Rao DR. Whole body, liver and plasma cholesterol levels in rats fed thermophilus, bulgaricus and acidophilus milks J. Food Sci. 48: 280 - 281 (1983).
Rautio M, Jousimics-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, Koskela M. Liver abscess due to Lactobacillus rhamnosus strain indistinguishable from L. ramnosus strain GG. Clin. Infect. Dis. 28 (5): 1159 – 1160 (1999).
Reddy GV, Friend B, Shahanim K and Farmer R. Antitumor activity of yogurt components. J. Food protection. 46: 8 -11 (1983).
Reid G, Jass J, Sebulsky MT and Cormick JK. Potential uses of probiotics in clinical practice. Clin. Microbiol. Rev. 16 (4): 658 – 672 (2003).
Reid G. The scientific basis for probiotic strains of Lactobacillus. Appl. Environ. Microbiol. 65 (9): 3763 – 3766 (1999).
Saxelin M, Tynkkynen S, Mattila _ Sandholm T and de Vos WM. Probiotic and other functional microbes: from markets to mechanisms. Curr. Opinion Biotechnol. 16: 204 – 211 (2005).
Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalatzopoulos G, Tsakalidou E and Mentis A. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei shirota. Appl. Environm. Microbiol. 70: 518 -526 (2004).
Shahani KM, Friend B, and Bailey P. Antitumor activity of fermented colostrums and milk. J. Food Protection. 46: 385 -386 (1983).
Soek et al. Lowering of serum cholesterol by Lactobacilus s porogens. J. Pharma. Soc. Korea. 31 (5): 302-307 (1987).
Speck ML. Interactions among lactobacilli and men. J. Dairy Sci. 59: 338 (1976).
Spinosa MR, Bracciini T, Ricca E, DeFlice M, Morelli L, Pozzi G and Oggioni MR. On the fate 0f ingested Bacillus and spores. Res. Microbiol. 151 (5): 361 – 368 (2000).
Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J and van Belle G. Prevention of antibiotic associated diarrhea by Saccharomyces boulardii, a prospective study. Gastroenterology. 96: 981 – 988 (1989).
Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M and Mikolajezyk W. Efficacy of Lactobacillus sp strain GG in prevention of nosocominal diarrhea in infants. J. Pediatr. Gastroenterol. Nutr. 138: 361 – 365 (2001).
Taumola E, Playne M and Salminen S. Quality assurance criteria for probiotic bacteria. Am. J. Clin. Nutr. 73: 393S – 398S (2001).
Veld HJJ, Havenaar R and Marteau P. Establishing a scientific basis for probiotic R & D. Trends in Biotechnol. 12: 6-8 (1994).
Wang KY, Li SN, Liu CS, Perng DS, Su YC, WU DC, Jan CM, Lai CH, Wang TN and Wang WM. Effect of injesting Lactobacillus and Bifidobacterium containing yougurt in subjects with colonized Helicobacter pylori. Am. J. Clin. Nutr. 80: 737 – 741 (2004).
Wood BJB. The lactic acid bacteria in health and disease. Vol. 1, pp 151 – 192, Elsevier Applied Science.
www.fao.org
www.effca.com
Allen SJ, Okoko B, Martinez E, Gregorio G and Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Sys. Rev. 2: CD003048 (2004).
Blakey JL, Lubitz L, N. Campbell NT, Gillam GL, Bishop RF and Barnes GL. Enteric colonization in sporadic neonatal necrotizing enterocolitis. J. Pediatr. Gastroenterol. Nutr. 4: 591 – 595 (1985).
Drasar BS and Shah NP. Human intestinal flora, Academic press, New York, NY, 1974.
Friend BA, Fermer R and Shahami K. Effect of feeding and intraperitonial implantation of yogurt culture cells on Ehrlich ascites tumor. Milchwissens Chaft. 37: 708 -710 (1982).
Giacinto CD, Marinaro M, Sanchez M, Strober W and Boirivant M. Probiotic ameliorate recurrent Th1 – mediated murine colitis by inducing IL-10 and IL – 10 dependent TGF-beta bearing regulatory cells. J. Immunol. 174 (6): 3237 -3246 (2005).
Gill HS and Guarner F. Probiotics and human health: a clinical prespective, Postgraduate Med J. 80: 516 – 526 (2004).
Gilliland SE and Speck ML. Deconjugation of bile acids by intestenal lactobacilli. Appl. Environ. Microbiol. 33: 15 (1977).
Gilliland SE, Nelson CR, and Maxwell C. Assimilation of cholesterol by Lactobacillus acidophilus. Appl. Environ. Microbiol. 49: 337 – 381 (1985).
Goltz V, Romankiewiez JA, Moss J and Murr HV. Prophylaxis against ampicillin associated diarrhea with Lactobacillus preparation. Am. J. Hosp. Pharm. 36: 754 (1974).
Guarino A, Canani RB, Spagnuolo MI, Albano F and Benedetto LD. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J. Pediatr. Gastroenterol. Nutr. 25: 516-519 (1997).
Harmsen HJM, Raangas GC, He T, Degener JE and Welling GW. Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl. Environ. Microbiol. 68: 2982 – 2990 (2002).
Hennequin C, Kauffman-Lacroix C, Jobett A, Viard JP, Ricour C, Jaequemin JL and Berohe P. Possible role of Catheters in Saccharomyes boulardii fungemia. Eu. J. Clin. Microbiol. Infect. Dis. 40 (4): 970-975 (2000).
Hepner G, Fried R, Jeors S, Fuselt L and Morin R. Hypercholesterolemic effect of yogurt and milk. Am. J. Clin. Nutr. 32: 19 -24 (1979).
Holzer M, Mayrhuber E, Danner H and Braun H. The role of Lactobacillus buchneri in forge preservation. Trends Biotechnol. 21 (6): 282 -286 (2003).
Hosono A, Kashina T and Kada T. Antimutagenic properties of lactic acid cultered milk on chemical and fecal mutgens. J. Dairy Sci. 69: 2237 -2242 (1986).
Hosono A, Yoshimura A and Tani O. Antimutagenic activity of cellular component of Streptococcus faecalis IFO12965. Netherlands Milk and Dairy Journal. 41: 239 -245 (1987).
Kilara A and Shahani KM. Lactose activity of cultured and acidified dairy products. J. Dairy Sci. 61: 2031 – 2035 (1976).
Kruis W, Fric P, Pokotnicks J, Lukas M, Fixa B, Kascak M, Kamm MA, Weismulen J, Beglinger C, Stolte M, Wolf C and Wchulze J. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is an effective as with standard mesalazine. Gut. 53 (110): 1617 – 1623 (2004).
Kruszewska D, Lan, J, Lorca G, Yanagisawa N, Marklinder I and Ljungh A. Selection of lactic acid bacteria as probiotic strains by in vitro tests. Microb. Ecol. Health Dis. 29: 37 -49 (2002).
Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM. Lactobacillus endocarditis caused by a probiotic organism. Clin. Microbiol. Infect. 5(5): 290 – 292 (1999).
Majamaa H, Isolauri E, Saxelin M and Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroentitis. J. Pediatr. Gastroenterol. Nutr. 20: 333-338 (1995).
Mastsumoto S, Hara T, Hori T, Mitsuyama K, Nagaka M, Tomiyasu N, Suzuki A and Sata M. 2005. Probiotic Lactobacillus-induced improved in murine chronic inflammatory bowel disease is associated with down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin. Exp. Immunol. 14: 417 -426 (2005).
Meydani SN and Ha WK. Immunologic effects of yogurt. Am. J. clin. Nutr. 17: 861 -872 (2000).
Michalkiewicz J, Kortkiewski M, Gackowska L, Wayszomirska-Golda M, Helmin-Bara A, Dzierzanowa D and Madalinski K. Immunomodulatory effectds of lactic acid bacteria on human pherpheral blood mononuclear cells. Microb. Ecol. Health Dis. 15: 185-192 (2003).
Mimura T, Kaminishi M and Kamm MA. Diagnostic evaluation of patients with faecal incintinence at a specialist institution. Dig. Surg. 21 (30): 235 -241 (2004).
Osvath R. FDA food advisory committee to discuss criteria for safety of probiotics. Food Chem. News. 42: 12 (2000).
Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am. J. Gastroenterol. 95: S11 – S13 (2000).
Pulusani SR and Rao DR. Whole body, liver and plasma cholesterol levels in rats fed thermophilus, bulgaricus and acidophilus milks J. Food Sci. 48: 280 - 281 (1983).
Rautio M, Jousimics-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, Koskela M. Liver abscess due to Lactobacillus rhamnosus strain indistinguishable from L. ramnosus strain GG. Clin. Infect. Dis. 28 (5): 1159 – 1160 (1999).
Reddy GV, Friend B, Shahanim K and Farmer R. Antitumor activity of yogurt components. J. Food protection. 46: 8 -11 (1983).
Reid G, Jass J, Sebulsky MT and Cormick JK. Potential uses of probiotics in clinical practice. Clin. Microbiol. Rev. 16 (4): 658 – 672 (2003).
Reid G. The scientific basis for probiotic strains of Lactobacillus. Appl. Environ. Microbiol. 65 (9): 3763 – 3766 (1999).
Saxelin M, Tynkkynen S, Mattila _ Sandholm T and de Vos WM. Probiotic and other functional microbes: from markets to mechanisms. Curr. Opinion Biotechnol. 16: 204 – 211 (2005).
Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalatzopoulos G, Tsakalidou E and Mentis A. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei shirota. Appl. Environm. Microbiol. 70: 518 -526 (2004).
Shahani KM, Friend B, and Bailey P. Antitumor activity of fermented colostrums and milk. J. Food Protection. 46: 385 -386 (1983).
Soek et al. Lowering of serum cholesterol by Lactobacilus s porogens. J. Pharma. Soc. Korea. 31 (5): 302-307 (1987).
Speck ML. Interactions among lactobacilli and men. J. Dairy Sci. 59: 338 (1976).
Spinosa MR, Bracciini T, Ricca E, DeFlice M, Morelli L, Pozzi G and Oggioni MR. On the fate 0f ingested Bacillus and spores. Res. Microbiol. 151 (5): 361 – 368 (2000).
Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J and van Belle G. Prevention of antibiotic associated diarrhea by Saccharomyces boulardii, a prospective study. Gastroenterology. 96: 981 – 988 (1989).
Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M and Mikolajezyk W. Efficacy of Lactobacillus sp strain GG in prevention of nosocominal diarrhea in infants. J. Pediatr. Gastroenterol. Nutr. 138: 361 – 365 (2001).
Taumola E, Playne M and Salminen S. Quality assurance criteria for probiotic bacteria. Am. J. Clin. Nutr. 73: 393S – 398S (2001).
Veld HJJ, Havenaar R and Marteau P. Establishing a scientific basis for probiotic R & D. Trends in Biotechnol. 12: 6-8 (1994).
Wang KY, Li SN, Liu CS, Perng DS, Su YC, WU DC, Jan CM, Lai CH, Wang TN and Wang WM. Effect of injesting Lactobacillus and Bifidobacterium containing yougurt in subjects with colonized Helicobacter pylori. Am. J. Clin. Nutr. 80: 737 – 741 (2004).
Wood BJB. The lactic acid bacteria in health and disease. Vol. 1, pp 151 – 192, Elsevier Applied Science.
www.fao.org
www.effca.com
